Medical Care
Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Research Report 2025
- May 12, 25
- ID: 237071
- Pages: 108
- Figures: 107
- Views: 1
The global market for Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) was valued at US$ 21130 million in the year 2024 and is projected to reach a revised size of US$ 80670 million by 2031, growing at a CAGR of 21.4% during the forecast period.
Circulating tumor cells (CTCs) are tumor cells that detach from the primary tumor and travel in the bloodstream, spreading from the original tumor to other locations, leading to cancer metastasis. These cells exist in peripheral blood of cancer patients and detection of CTCs can help to determine the process of metastasis. In contrast with other blood cells, the number of CTCs is very rare in blood which makes them difficult to detect.
Cancer stem cells (CSCs) are cancer cells that have all the classical properties of normal stem cells. Specifically, they are able to both give rise to more copies of themselves and to give rise to all cell types found in the cancer.
The major players in global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market include Janssen, Qiagen, Advanced Cell Diagnostics, etc. North America and Europe are main markets, they occupy about 65% of the global market. CellSearch is the main type, with a share about 70%. Breast Cancer Diagnosis and Treatment, Colorectal Cancer Diagnosis and Treatment are main applications, which hold a share about 60%.
This report aims to provide a comprehensive presentation of the global market for Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs).
The Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Janssen
Qiagen
Advanced Cell Diagnostics
ApoCell
Biofluidica
Clearbridge Biomedics
CytoTrack
Celsee
Fluxion
Gilupi
Cynvenio
On-chip
YZY Bio
BioView
Fluidigm
Ikonisys
AdnaGen
IVDiagnostics
Miltenyi Biotec
ScreenCell
Silicon Biosystems
Segment by Type
CellSearch
Others
Segment by Application
Breast Cancer Diagnosis and Treatment
Prostate Cancer Diagnosis and Treatment
Colorectal Cancer Diagnosis and Treatment
Lung Cancer Diagnosis and Treatment
Other Cancers Diagnosis and Treatment
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Circulating tumor cells (CTCs) are tumor cells that detach from the primary tumor and travel in the bloodstream, spreading from the original tumor to other locations, leading to cancer metastasis. These cells exist in peripheral blood of cancer patients and detection of CTCs can help to determine the process of metastasis. In contrast with other blood cells, the number of CTCs is very rare in blood which makes them difficult to detect.
Cancer stem cells (CSCs) are cancer cells that have all the classical properties of normal stem cells. Specifically, they are able to both give rise to more copies of themselves and to give rise to all cell types found in the cancer.
The major players in global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market include Janssen, Qiagen, Advanced Cell Diagnostics, etc. North America and Europe are main markets, they occupy about 65% of the global market. CellSearch is the main type, with a share about 70%. Breast Cancer Diagnosis and Treatment, Colorectal Cancer Diagnosis and Treatment are main applications, which hold a share about 60%.
This report aims to provide a comprehensive presentation of the global market for Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs).
The Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Janssen
Qiagen
Advanced Cell Diagnostics
ApoCell
Biofluidica
Clearbridge Biomedics
CytoTrack
Celsee
Fluxion
Gilupi
Cynvenio
On-chip
YZY Bio
BioView
Fluidigm
Ikonisys
AdnaGen
IVDiagnostics
Miltenyi Biotec
ScreenCell
Silicon Biosystems
Segment by Type
CellSearch
Others
Segment by Application
Breast Cancer Diagnosis and Treatment
Prostate Cancer Diagnosis and Treatment
Colorectal Cancer Diagnosis and Treatment
Lung Cancer Diagnosis and Treatment
Other Cancers Diagnosis and Treatment
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 CellSearch
1.2.3 Others
1.3 Market by Application
1.3.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Breast Cancer Diagnosis and Treatment
1.3.3 Prostate Cancer Diagnosis and Treatment
1.3.4 Colorectal Cancer Diagnosis and Treatment
1.3.5 Lung Cancer Diagnosis and Treatment
1.3.6 Other Cancers Diagnosis and Treatment
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Perspective (2020-2031)
2.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Growth Trends by Region
2.2.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Historic Market Size by Region (2020-2025)
2.2.3 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Forecasted Market Size by Region (2026-2031)
2.3 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Dynamics
2.3.1 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry Trends
2.3.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Drivers
2.3.3 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Challenges
2.3.4 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Players by Revenue
3.1.1 Global Top Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Players by Revenue (2020-2025)
3.1.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share by Players (2020-2025)
3.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue
3.4 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Concentration Ratio
3.4.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in 2024
3.5 Global Key Players of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Head office and Area Served
3.6 Global Key Players of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs), Product and Application
3.7 Global Key Players of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Breakdown Data by Type
4.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Historic Market Size by Type (2020-2025)
4.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Forecasted Market Size by Type (2026-2031)
5 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Breakdown Data by Application
5.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Historic Market Size by Application (2020-2025)
5.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size (2020-2031)
6.2 North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2020-2025)
6.4 North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size (2020-2031)
7.2 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2020-2025)
7.4 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size (2020-2031)
8.2 Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Region (2020-2025)
8.4 Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size (2020-2031)
9.2 Latin America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2020-2025)
9.4 Latin America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size (2020-2031)
10.2 Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2020-2025)
10.4 Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Janssen
11.1.1 Janssen Company Details
11.1.2 Janssen Business Overview
11.1.3 Janssen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
11.1.4 Janssen Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
11.1.5 Janssen Recent Development
11.2 Qiagen
11.2.1 Qiagen Company Details
11.2.2 Qiagen Business Overview
11.2.3 Qiagen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
11.2.4 Qiagen Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
11.2.5 Qiagen Recent Development
11.3 Advanced Cell Diagnostics
11.3.1 Advanced Cell Diagnostics Company Details
11.3.2 Advanced Cell Diagnostics Business Overview
11.3.3 Advanced Cell Diagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
11.3.4 Advanced Cell Diagnostics Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
11.3.5 Advanced Cell Diagnostics Recent Development
11.4 ApoCell
11.4.1 ApoCell Company Details
11.4.2 ApoCell Business Overview
11.4.3 ApoCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
11.4.4 ApoCell Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
11.4.5 ApoCell Recent Development
11.5 Biofluidica
11.5.1 Biofluidica Company Details
11.5.2 Biofluidica Business Overview
11.5.3 Biofluidica Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
11.5.4 Biofluidica Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
11.5.5 Biofluidica Recent Development
11.6 Clearbridge Biomedics
11.6.1 Clearbridge Biomedics Company Details
11.6.2 Clearbridge Biomedics Business Overview
11.6.3 Clearbridge Biomedics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
11.6.4 Clearbridge Biomedics Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
11.6.5 Clearbridge Biomedics Recent Development
11.7 CytoTrack
11.7.1 CytoTrack Company Details
11.7.2 CytoTrack Business Overview
11.7.3 CytoTrack Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
11.7.4 CytoTrack Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
11.7.5 CytoTrack Recent Development
11.8 Celsee
11.8.1 Celsee Company Details
11.8.2 Celsee Business Overview
11.8.3 Celsee Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
11.8.4 Celsee Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
11.8.5 Celsee Recent Development
11.9 Fluxion
11.9.1 Fluxion Company Details
11.9.2 Fluxion Business Overview
11.9.3 Fluxion Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
11.9.4 Fluxion Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
11.9.5 Fluxion Recent Development
11.10 Gilupi
11.10.1 Gilupi Company Details
11.10.2 Gilupi Business Overview
11.10.3 Gilupi Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
11.10.4 Gilupi Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
11.10.5 Gilupi Recent Development
11.11 Cynvenio
11.11.1 Cynvenio Company Details
11.11.2 Cynvenio Business Overview
11.11.3 Cynvenio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
11.11.4 Cynvenio Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
11.11.5 Cynvenio Recent Development
11.12 On-chip
11.12.1 On-chip Company Details
11.12.2 On-chip Business Overview
11.12.3 On-chip Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
11.12.4 On-chip Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
11.12.5 On-chip Recent Development
11.13 YZY Bio
11.13.1 YZY Bio Company Details
11.13.2 YZY Bio Business Overview
11.13.3 YZY Bio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
11.13.4 YZY Bio Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
11.13.5 YZY Bio Recent Development
11.14 BioView
11.14.1 BioView Company Details
11.14.2 BioView Business Overview
11.14.3 BioView Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
11.14.4 BioView Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
11.14.5 BioView Recent Development
11.15 Fluidigm
11.15.1 Fluidigm Company Details
11.15.2 Fluidigm Business Overview
11.15.3 Fluidigm Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
11.15.4 Fluidigm Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
11.15.5 Fluidigm Recent Development
11.16 Ikonisys
11.16.1 Ikonisys Company Details
11.16.2 Ikonisys Business Overview
11.16.3 Ikonisys Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
11.16.4 Ikonisys Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
11.16.5 Ikonisys Recent Development
11.17 AdnaGen
11.17.1 AdnaGen Company Details
11.17.2 AdnaGen Business Overview
11.17.3 AdnaGen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
11.17.4 AdnaGen Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
11.17.5 AdnaGen Recent Development
11.18 IVDiagnostics
11.18.1 IVDiagnostics Company Details
11.18.2 IVDiagnostics Business Overview
11.18.3 IVDiagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
11.18.4 IVDiagnostics Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
11.18.5 IVDiagnostics Recent Development
11.19 Miltenyi Biotec
11.19.1 Miltenyi Biotec Company Details
11.19.2 Miltenyi Biotec Business Overview
11.19.3 Miltenyi Biotec Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
11.19.4 Miltenyi Biotec Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
11.19.5 Miltenyi Biotec Recent Development
11.20 ScreenCell
11.20.1 ScreenCell Company Details
11.20.2 ScreenCell Business Overview
11.20.3 ScreenCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
11.20.4 ScreenCell Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
11.20.5 ScreenCell Recent Development
11.21 Silicon Biosystems
11.21.1 Silicon Biosystems Company Details
11.21.2 Silicon Biosystems Business Overview
11.21.3 Silicon Biosystems Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
11.21.4 Silicon Biosystems Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
11.21.5 Silicon Biosystems Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 CellSearch
1.2.3 Others
1.3 Market by Application
1.3.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Breast Cancer Diagnosis and Treatment
1.3.3 Prostate Cancer Diagnosis and Treatment
1.3.4 Colorectal Cancer Diagnosis and Treatment
1.3.5 Lung Cancer Diagnosis and Treatment
1.3.6 Other Cancers Diagnosis and Treatment
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Perspective (2020-2031)
2.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Growth Trends by Region
2.2.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Historic Market Size by Region (2020-2025)
2.2.3 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Forecasted Market Size by Region (2026-2031)
2.3 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Dynamics
2.3.1 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry Trends
2.3.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Drivers
2.3.3 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Challenges
2.3.4 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Players by Revenue
3.1.1 Global Top Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Players by Revenue (2020-2025)
3.1.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share by Players (2020-2025)
3.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue
3.4 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Concentration Ratio
3.4.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in 2024
3.5 Global Key Players of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Head office and Area Served
3.6 Global Key Players of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs), Product and Application
3.7 Global Key Players of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Breakdown Data by Type
4.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Historic Market Size by Type (2020-2025)
4.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Forecasted Market Size by Type (2026-2031)
5 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Breakdown Data by Application
5.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Historic Market Size by Application (2020-2025)
5.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size (2020-2031)
6.2 North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2020-2025)
6.4 North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size (2020-2031)
7.2 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2020-2025)
7.4 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size (2020-2031)
8.2 Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Region (2020-2025)
8.4 Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size (2020-2031)
9.2 Latin America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2020-2025)
9.4 Latin America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size (2020-2031)
10.2 Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2020-2025)
10.4 Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Janssen
11.1.1 Janssen Company Details
11.1.2 Janssen Business Overview
11.1.3 Janssen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
11.1.4 Janssen Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
11.1.5 Janssen Recent Development
11.2 Qiagen
11.2.1 Qiagen Company Details
11.2.2 Qiagen Business Overview
11.2.3 Qiagen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
11.2.4 Qiagen Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
11.2.5 Qiagen Recent Development
11.3 Advanced Cell Diagnostics
11.3.1 Advanced Cell Diagnostics Company Details
11.3.2 Advanced Cell Diagnostics Business Overview
11.3.3 Advanced Cell Diagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
11.3.4 Advanced Cell Diagnostics Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
11.3.5 Advanced Cell Diagnostics Recent Development
11.4 ApoCell
11.4.1 ApoCell Company Details
11.4.2 ApoCell Business Overview
11.4.3 ApoCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
11.4.4 ApoCell Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
11.4.5 ApoCell Recent Development
11.5 Biofluidica
11.5.1 Biofluidica Company Details
11.5.2 Biofluidica Business Overview
11.5.3 Biofluidica Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
11.5.4 Biofluidica Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
11.5.5 Biofluidica Recent Development
11.6 Clearbridge Biomedics
11.6.1 Clearbridge Biomedics Company Details
11.6.2 Clearbridge Biomedics Business Overview
11.6.3 Clearbridge Biomedics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
11.6.4 Clearbridge Biomedics Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
11.6.5 Clearbridge Biomedics Recent Development
11.7 CytoTrack
11.7.1 CytoTrack Company Details
11.7.2 CytoTrack Business Overview
11.7.3 CytoTrack Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
11.7.4 CytoTrack Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
11.7.5 CytoTrack Recent Development
11.8 Celsee
11.8.1 Celsee Company Details
11.8.2 Celsee Business Overview
11.8.3 Celsee Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
11.8.4 Celsee Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
11.8.5 Celsee Recent Development
11.9 Fluxion
11.9.1 Fluxion Company Details
11.9.2 Fluxion Business Overview
11.9.3 Fluxion Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
11.9.4 Fluxion Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
11.9.5 Fluxion Recent Development
11.10 Gilupi
11.10.1 Gilupi Company Details
11.10.2 Gilupi Business Overview
11.10.3 Gilupi Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
11.10.4 Gilupi Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
11.10.5 Gilupi Recent Development
11.11 Cynvenio
11.11.1 Cynvenio Company Details
11.11.2 Cynvenio Business Overview
11.11.3 Cynvenio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
11.11.4 Cynvenio Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
11.11.5 Cynvenio Recent Development
11.12 On-chip
11.12.1 On-chip Company Details
11.12.2 On-chip Business Overview
11.12.3 On-chip Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
11.12.4 On-chip Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
11.12.5 On-chip Recent Development
11.13 YZY Bio
11.13.1 YZY Bio Company Details
11.13.2 YZY Bio Business Overview
11.13.3 YZY Bio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
11.13.4 YZY Bio Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
11.13.5 YZY Bio Recent Development
11.14 BioView
11.14.1 BioView Company Details
11.14.2 BioView Business Overview
11.14.3 BioView Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
11.14.4 BioView Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
11.14.5 BioView Recent Development
11.15 Fluidigm
11.15.1 Fluidigm Company Details
11.15.2 Fluidigm Business Overview
11.15.3 Fluidigm Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
11.15.4 Fluidigm Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
11.15.5 Fluidigm Recent Development
11.16 Ikonisys
11.16.1 Ikonisys Company Details
11.16.2 Ikonisys Business Overview
11.16.3 Ikonisys Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
11.16.4 Ikonisys Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
11.16.5 Ikonisys Recent Development
11.17 AdnaGen
11.17.1 AdnaGen Company Details
11.17.2 AdnaGen Business Overview
11.17.3 AdnaGen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
11.17.4 AdnaGen Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
11.17.5 AdnaGen Recent Development
11.18 IVDiagnostics
11.18.1 IVDiagnostics Company Details
11.18.2 IVDiagnostics Business Overview
11.18.3 IVDiagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
11.18.4 IVDiagnostics Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
11.18.5 IVDiagnostics Recent Development
11.19 Miltenyi Biotec
11.19.1 Miltenyi Biotec Company Details
11.19.2 Miltenyi Biotec Business Overview
11.19.3 Miltenyi Biotec Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
11.19.4 Miltenyi Biotec Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
11.19.5 Miltenyi Biotec Recent Development
11.20 ScreenCell
11.20.1 ScreenCell Company Details
11.20.2 ScreenCell Business Overview
11.20.3 ScreenCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
11.20.4 ScreenCell Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
11.20.5 ScreenCell Recent Development
11.21 Silicon Biosystems
11.21.1 Silicon Biosystems Company Details
11.21.2 Silicon Biosystems Business Overview
11.21.3 Silicon Biosystems Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Introduction
11.21.4 Silicon Biosystems Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
11.21.5 Silicon Biosystems Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of CellSearch
Table 3. Key Players of Others
Table 4. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Region (2020-2025)
Table 8. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Region (2026-2031)
Table 10. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Trends
Table 11. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Drivers
Table 12. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Challenges
Table 13. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Restraints
Table 14. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Players (2020-2025)
Table 16. Global Top Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) as of 2024)
Table 17. Ranking of Global Top Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs), Headquarters and Area Served
Table 20. Global Key Players of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs), Product and Application
Table 21. Global Key Players of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs), Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share by Type (2020-2025)
Table 25. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share by Type (2026-2031)
Table 27. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share by Application (2020-2025)
Table 29. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share by Application (2026-2031)
Table 31. North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2026-2031) & (US$ Million)
Table 46. Janssen Company Details
Table 47. Janssen Business Overview
Table 48. Janssen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product
Table 49. Janssen Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025) & (US$ Million)
Table 50. Janssen Recent Development
Table 51. Qiagen Company Details
Table 52. Qiagen Business Overview
Table 53. Qiagen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product
Table 54. Qiagen Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025) & (US$ Million)
Table 55. Qiagen Recent Development
Table 56. Advanced Cell Diagnostics Company Details
Table 57. Advanced Cell Diagnostics Business Overview
Table 58. Advanced Cell Diagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product
Table 59. Advanced Cell Diagnostics Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025) & (US$ Million)
Table 60. Advanced Cell Diagnostics Recent Development
Table 61. ApoCell Company Details
Table 62. ApoCell Business Overview
Table 63. ApoCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product
Table 64. ApoCell Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025) & (US$ Million)
Table 65. ApoCell Recent Development
Table 66. Biofluidica Company Details
Table 67. Biofluidica Business Overview
Table 68. Biofluidica Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product
Table 69. Biofluidica Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025) & (US$ Million)
Table 70. Biofluidica Recent Development
Table 71. Clearbridge Biomedics Company Details
Table 72. Clearbridge Biomedics Business Overview
Table 73. Clearbridge Biomedics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product
Table 74. Clearbridge Biomedics Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025) & (US$ Million)
Table 75. Clearbridge Biomedics Recent Development
Table 76. CytoTrack Company Details
Table 77. CytoTrack Business Overview
Table 78. CytoTrack Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product
Table 79. CytoTrack Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025) & (US$ Million)
Table 80. CytoTrack Recent Development
Table 81. Celsee Company Details
Table 82. Celsee Business Overview
Table 83. Celsee Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product
Table 84. Celsee Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025) & (US$ Million)
Table 85. Celsee Recent Development
Table 86. Fluxion Company Details
Table 87. Fluxion Business Overview
Table 88. Fluxion Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product
Table 89. Fluxion Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025) & (US$ Million)
Table 90. Fluxion Recent Development
Table 91. Gilupi Company Details
Table 92. Gilupi Business Overview
Table 93. Gilupi Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product
Table 94. Gilupi Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025) & (US$ Million)
Table 95. Gilupi Recent Development
Table 96. Cynvenio Company Details
Table 97. Cynvenio Business Overview
Table 98. Cynvenio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product
Table 99. Cynvenio Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025) & (US$ Million)
Table 100. Cynvenio Recent Development
Table 101. On-chip Company Details
Table 102. On-chip Business Overview
Table 103. On-chip Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product
Table 104. On-chip Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025) & (US$ Million)
Table 105. On-chip Recent Development
Table 106. YZY Bio Company Details
Table 107. YZY Bio Business Overview
Table 108. YZY Bio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product
Table 109. YZY Bio Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025) & (US$ Million)
Table 110. YZY Bio Recent Development
Table 111. BioView Company Details
Table 112. BioView Business Overview
Table 113. BioView Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product
Table 114. BioView Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025) & (US$ Million)
Table 115. BioView Recent Development
Table 116. Fluidigm Company Details
Table 117. Fluidigm Business Overview
Table 118. Fluidigm Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product
Table 119. Fluidigm Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025) & (US$ Million)
Table 120. Fluidigm Recent Development
Table 121. Ikonisys Company Details
Table 122. Ikonisys Business Overview
Table 123. Ikonisys Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product
Table 124. Ikonisys Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025) & (US$ Million)
Table 125. Ikonisys Recent Development
Table 126. AdnaGen Company Details
Table 127. AdnaGen Business Overview
Table 128. AdnaGen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product
Table 129. AdnaGen Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025) & (US$ Million)
Table 130. AdnaGen Recent Development
Table 131. IVDiagnostics Company Details
Table 132. IVDiagnostics Business Overview
Table 133. IVDiagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product
Table 134. IVDiagnostics Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025) & (US$ Million)
Table 135. IVDiagnostics Recent Development
Table 136. Miltenyi Biotec Company Details
Table 137. Miltenyi Biotec Business Overview
Table 138. Miltenyi Biotec Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product
Table 139. Miltenyi Biotec Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025) & (US$ Million)
Table 140. Miltenyi Biotec Recent Development
Table 141. ScreenCell Company Details
Table 142. ScreenCell Business Overview
Table 143. ScreenCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product
Table 144. ScreenCell Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025) & (US$ Million)
Table 145. ScreenCell Recent Development
Table 146. Silicon Biosystems Company Details
Table 147. Silicon Biosystems Business Overview
Table 148. Silicon Biosystems Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product
Table 149. Silicon Biosystems Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025) & (US$ Million)
Table 150. Silicon Biosystems Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
Table 154. Authors List of This Report
List of Figures
Figure 1. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Picture
Figure 2. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Type: 2024 VS 2031
Figure 4. CellSearch Features
Figure 5. Others Features
Figure 6. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Application: 2024 VS 2031
Figure 8. Breast Cancer Diagnosis and Treatment Case Studies
Figure 9. Prostate Cancer Diagnosis and Treatment Case Studies
Figure 10. Colorectal Cancer Diagnosis and Treatment Case Studies
Figure 11. Lung Cancer Diagnosis and Treatment Case Studies
Figure 12. Other Cancers Diagnosis and Treatment Case Studies
Figure 13. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Report Years Considered
Figure 14. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Region: 2024 VS 2031
Figure 17. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Players in 2024
Figure 18. Global Top Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in 2024
Figure 20. North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Country (2020-2031)
Figure 22. United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Country (2020-2031)
Figure 26. Germany Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Region (2020-2031)
Figure 34. China Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Country (2020-2031)
Figure 42. Mexico Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Country (2020-2031)
Figure 46. Turkey Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Janssen Revenue Growth Rate in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
Figure 50. Qiagen Revenue Growth Rate in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
Figure 51. Advanced Cell Diagnostics Revenue Growth Rate in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
Figure 52. ApoCell Revenue Growth Rate in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
Figure 53. Biofluidica Revenue Growth Rate in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
Figure 54. Clearbridge Biomedics Revenue Growth Rate in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
Figure 55. CytoTrack Revenue Growth Rate in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
Figure 56. Celsee Revenue Growth Rate in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
Figure 57. Fluxion Revenue Growth Rate in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
Figure 58. Gilupi Revenue Growth Rate in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
Figure 59. Cynvenio Revenue Growth Rate in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
Figure 60. On-chip Revenue Growth Rate in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
Figure 61. YZY Bio Revenue Growth Rate in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
Figure 62. BioView Revenue Growth Rate in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
Figure 63. Fluidigm Revenue Growth Rate in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
Figure 64. Ikonisys Revenue Growth Rate in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
Figure 65. AdnaGen Revenue Growth Rate in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
Figure 66. IVDiagnostics Revenue Growth Rate in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
Figure 67. Miltenyi Biotec Revenue Growth Rate in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
Figure 68. ScreenCell Revenue Growth Rate in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
Figure 69. Silicon Biosystems Revenue Growth Rate in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Table 1. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of CellSearch
Table 3. Key Players of Others
Table 4. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Region (2020-2025)
Table 8. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Region (2026-2031)
Table 10. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Trends
Table 11. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Drivers
Table 12. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Challenges
Table 13. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Restraints
Table 14. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Players (2020-2025)
Table 16. Global Top Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) as of 2024)
Table 17. Ranking of Global Top Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs), Headquarters and Area Served
Table 20. Global Key Players of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs), Product and Application
Table 21. Global Key Players of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs), Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share by Type (2020-2025)
Table 25. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share by Type (2026-2031)
Table 27. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share by Application (2020-2025)
Table 29. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share by Application (2026-2031)
Table 31. North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2026-2031) & (US$ Million)
Table 46. Janssen Company Details
Table 47. Janssen Business Overview
Table 48. Janssen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product
Table 49. Janssen Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025) & (US$ Million)
Table 50. Janssen Recent Development
Table 51. Qiagen Company Details
Table 52. Qiagen Business Overview
Table 53. Qiagen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product
Table 54. Qiagen Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025) & (US$ Million)
Table 55. Qiagen Recent Development
Table 56. Advanced Cell Diagnostics Company Details
Table 57. Advanced Cell Diagnostics Business Overview
Table 58. Advanced Cell Diagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product
Table 59. Advanced Cell Diagnostics Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025) & (US$ Million)
Table 60. Advanced Cell Diagnostics Recent Development
Table 61. ApoCell Company Details
Table 62. ApoCell Business Overview
Table 63. ApoCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product
Table 64. ApoCell Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025) & (US$ Million)
Table 65. ApoCell Recent Development
Table 66. Biofluidica Company Details
Table 67. Biofluidica Business Overview
Table 68. Biofluidica Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product
Table 69. Biofluidica Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025) & (US$ Million)
Table 70. Biofluidica Recent Development
Table 71. Clearbridge Biomedics Company Details
Table 72. Clearbridge Biomedics Business Overview
Table 73. Clearbridge Biomedics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product
Table 74. Clearbridge Biomedics Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025) & (US$ Million)
Table 75. Clearbridge Biomedics Recent Development
Table 76. CytoTrack Company Details
Table 77. CytoTrack Business Overview
Table 78. CytoTrack Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product
Table 79. CytoTrack Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025) & (US$ Million)
Table 80. CytoTrack Recent Development
Table 81. Celsee Company Details
Table 82. Celsee Business Overview
Table 83. Celsee Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product
Table 84. Celsee Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025) & (US$ Million)
Table 85. Celsee Recent Development
Table 86. Fluxion Company Details
Table 87. Fluxion Business Overview
Table 88. Fluxion Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product
Table 89. Fluxion Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025) & (US$ Million)
Table 90. Fluxion Recent Development
Table 91. Gilupi Company Details
Table 92. Gilupi Business Overview
Table 93. Gilupi Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product
Table 94. Gilupi Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025) & (US$ Million)
Table 95. Gilupi Recent Development
Table 96. Cynvenio Company Details
Table 97. Cynvenio Business Overview
Table 98. Cynvenio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product
Table 99. Cynvenio Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025) & (US$ Million)
Table 100. Cynvenio Recent Development
Table 101. On-chip Company Details
Table 102. On-chip Business Overview
Table 103. On-chip Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product
Table 104. On-chip Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025) & (US$ Million)
Table 105. On-chip Recent Development
Table 106. YZY Bio Company Details
Table 107. YZY Bio Business Overview
Table 108. YZY Bio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product
Table 109. YZY Bio Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025) & (US$ Million)
Table 110. YZY Bio Recent Development
Table 111. BioView Company Details
Table 112. BioView Business Overview
Table 113. BioView Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product
Table 114. BioView Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025) & (US$ Million)
Table 115. BioView Recent Development
Table 116. Fluidigm Company Details
Table 117. Fluidigm Business Overview
Table 118. Fluidigm Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product
Table 119. Fluidigm Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025) & (US$ Million)
Table 120. Fluidigm Recent Development
Table 121. Ikonisys Company Details
Table 122. Ikonisys Business Overview
Table 123. Ikonisys Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product
Table 124. Ikonisys Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025) & (US$ Million)
Table 125. Ikonisys Recent Development
Table 126. AdnaGen Company Details
Table 127. AdnaGen Business Overview
Table 128. AdnaGen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product
Table 129. AdnaGen Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025) & (US$ Million)
Table 130. AdnaGen Recent Development
Table 131. IVDiagnostics Company Details
Table 132. IVDiagnostics Business Overview
Table 133. IVDiagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product
Table 134. IVDiagnostics Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025) & (US$ Million)
Table 135. IVDiagnostics Recent Development
Table 136. Miltenyi Biotec Company Details
Table 137. Miltenyi Biotec Business Overview
Table 138. Miltenyi Biotec Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product
Table 139. Miltenyi Biotec Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025) & (US$ Million)
Table 140. Miltenyi Biotec Recent Development
Table 141. ScreenCell Company Details
Table 142. ScreenCell Business Overview
Table 143. ScreenCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product
Table 144. ScreenCell Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025) & (US$ Million)
Table 145. ScreenCell Recent Development
Table 146. Silicon Biosystems Company Details
Table 147. Silicon Biosystems Business Overview
Table 148. Silicon Biosystems Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product
Table 149. Silicon Biosystems Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025) & (US$ Million)
Table 150. Silicon Biosystems Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
Table 154. Authors List of This Report
List of Figures
Figure 1. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Picture
Figure 2. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Type: 2024 VS 2031
Figure 4. CellSearch Features
Figure 5. Others Features
Figure 6. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Application: 2024 VS 2031
Figure 8. Breast Cancer Diagnosis and Treatment Case Studies
Figure 9. Prostate Cancer Diagnosis and Treatment Case Studies
Figure 10. Colorectal Cancer Diagnosis and Treatment Case Studies
Figure 11. Lung Cancer Diagnosis and Treatment Case Studies
Figure 12. Other Cancers Diagnosis and Treatment Case Studies
Figure 13. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Report Years Considered
Figure 14. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Region: 2024 VS 2031
Figure 17. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Players in 2024
Figure 18. Global Top Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue in 2024
Figure 20. North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Country (2020-2031)
Figure 22. United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Country (2020-2031)
Figure 26. Germany Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Region (2020-2031)
Figure 34. China Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Country (2020-2031)
Figure 42. Mexico Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Country (2020-2031)
Figure 46. Turkey Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Janssen Revenue Growth Rate in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
Figure 50. Qiagen Revenue Growth Rate in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
Figure 51. Advanced Cell Diagnostics Revenue Growth Rate in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
Figure 52. ApoCell Revenue Growth Rate in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
Figure 53. Biofluidica Revenue Growth Rate in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
Figure 54. Clearbridge Biomedics Revenue Growth Rate in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
Figure 55. CytoTrack Revenue Growth Rate in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
Figure 56. Celsee Revenue Growth Rate in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
Figure 57. Fluxion Revenue Growth Rate in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
Figure 58. Gilupi Revenue Growth Rate in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
Figure 59. Cynvenio Revenue Growth Rate in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
Figure 60. On-chip Revenue Growth Rate in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
Figure 61. YZY Bio Revenue Growth Rate in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
Figure 62. BioView Revenue Growth Rate in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
Figure 63. Fluidigm Revenue Growth Rate in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
Figure 64. Ikonisys Revenue Growth Rate in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
Figure 65. AdnaGen Revenue Growth Rate in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
Figure 66. IVDiagnostics Revenue Growth Rate in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
Figure 67. Miltenyi Biotec Revenue Growth Rate in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
Figure 68. ScreenCell Revenue Growth Rate in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
Figure 69. Silicon Biosystems Revenue Growth Rate in Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Business (2020-2025)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Krypton Flash Lamp Market Research Report 2025
May 12, 25
Global IR Halogen Lamp Market Research Report 2025
May 12, 25
Global Halogen IR Lamp Market Research Report 2025
May 12, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232